The Schreiner Group LP branch has been in existence since 2008. More than 80 employees now produce high-tech products for the entire North American market. The Blauvelt plant was founded by the current CEO Roland Schreiner, who at the time was head of the MediPharm business unit. Since then, it has grown, both in terms of employee numbers, sales and product diversity.
"Schreiner Group has performed very well in the U.S. over the past few years – now there is the opportunity to take the business to a new level of growth and expansion," Zumbolo stated. "I believe Schreiner Group still has great market potential in the United States. In the future, I see our potential as equaling that of the Schreiner Group business in Europe."




















